Epimmune, Anosys Nixed Merger Caused By Unsatisfied Conditions
Despite a long courtship, a summertime biotech romance appears to have fizzled.
Epimmune Inc. canceled its merger agreement with Anosys Inc., a deal first reported three months ago, and hired a financial adviser to consult on alternate strategies going forward. (BioWorld Today)
